Thanks Toinv for the detailed summary of OriStar leadership and ties with Hepa. It is comforting to know that Ori's holding 16 million RVX shares precludes any feared alliance with a Hepa takeover.
Two things have reinforced my continued investment. OriStar's confident common share investment and the teaming of Resverlogix with Eversana on product development.